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I will begin by telling a little about
the development of chronic dialysis. In
1959 we were working on a system to
prevent uremia in acute renal failure.
We were trying to develop a system to
which we could "hook" the patient
for as Jong as a week, so that we would
exactly mimic his normal kidney function during the period of acute renal
failure, and make his prognosis that
of a patient who had kidneys. The
system worked reasonably well. We
had to make a lot of modifications,
such as using a Skeggs-Leonard dialyzer with low resistance. We used a
large deep freeze as a dialysate reservoir because we could not afford to
change the bath every few hours. The
patient was on continuously. We had
to cool the external circuit to control
clotting problems and infection. We
actually had patients on this system for
as long as two weeks. It was important
to us that we had this system in operation at the time we first devised the
cannulas. (The cannulas were devised
by Dr. David Dillard, our surgical consultant, and Mr. Wayne Quinton. It is
amazing how well their original design
has held. As far as I know, it has not
been improved greatly, because the cannulas are still the weakest part of the
system.)
General Features of the Cannulas and
Shunt

The essential system has a long subcutaneous tunnel with a curve of 180°
into each vessel. The tunnel is to prevent infection, and the curve is to
stabilize the cannula in the vessel. The
system does not clot because one tube
is in the artery and one tube is in the
vein, and the blood runs through. Of
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course, it all depends on tefion for
non-clotting. Allwall had tried the idea
in 1944 and failed, because he was
using glass cannulas and rubber tubing; we had a tefion system exclusively.
This is the basic operating principle
of the system: when you want to treat
a patient, you simply pull off the shunt,
connect the tubing to the artificial kidney, and you can dialyze at will. The
best evidence I can give that this system works is the first chronic patient
ever to receive cannulas. He is Clyde
Shields, who now has been five-andone-half years on dialysis. He has not
passed any urine in over five years,
and is today in better health than at
any time. We had to learn on our first
patients how to manage chronic uremia
by dialysis. We did not know how
much dialysis it would take, we did
not know how to take care of the
cannulas, and we did not know what
complications to expect. Clyde has his
present cannulas in his leg. We used
up all the arm sites in the first few
months because the straight tefion
system would last only a few months
and not much longer. The new rubber
segment has made a great difference in
the cannula system. The nurse used
to put the heparin into the bloodstream. We no longer do this, but use
an infusion pump. Note, though, that
the nurse does the entire procedure.
In Seattle, dialysis is completely nursetechnician operated on the chronic
program, and doctors are not in attendance.
We had our clear plastic Kiil dialyzer built especially to study dialyzerfiow pattern. One of the things that is
so important is a better understanding
of what is going across these mem-
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branes. If we could really understand
what the chemicals are that we had to
move, and urea is one of them, then
we could build better membranes. As
far as the technique of dialyzer design, ours is a good one but it is not
perfect. There is streaming, and the
minute you get streaming in a dialyzer,
you loose efficiency. We had this particular version built to study the flow
patterns. This Kiil dialyzer is the design of Dr. Frederick Kiil in Oslo. He
took the original Skeggs design and
modified it so that it was easier to assemble, and more efficient to use. This
is the only dialyzer at the present time
that has been proven useful in the
treatment of chronics, because it is low
in resistance, small in blood volume,
and easy to assemble. When the blood
finally reaches the venous end of the
external circuit, the nurse plugs the
venous candula in and the patient is on
dialysis.
For some idea of the progress being
made in the technology, where we
could formerly only treat three patients, we can now take four, thanks
to the central pumping system which
takes concentrate from a tank, and uses
very accurate proportioning pumps.
They mix the concentrate with tap
water, which is monitored by a conductivity meter, and then the fluid is
pumped around the room to the various stations. The whole system is automatic. This then means that we fill
this concentrate tank about once a
month instead of filling a tank once a
day for each patient.
Results of Management by Dialysis

We recently conducted a survey on
the current state of dialysis around the
world. There are 12 centers that have
been in operation for longer than oneand-one-half years. There are seven,
and probably more, newer groups just
getting started. There have been 95
patients taken into treatment. There
have been 28 deaths. What is most important is that 75 % of the deaths have
occurred during the first year of each
program. This underscores the need
for adequate preparation, adequate
funding, adequate training of personnel, and adequate creation of facilities
especially for chronic dialysis . This

also means that a realistic approach to
the problem is needed, rather than the
helter-skelter one that is so tempting
when you are confronted with a dying
patient. The other 25 % of the deaths
were due to what we considered to be
natural causes. In other words, the
one patient who died in Seattle, died
one year after starting the program, of
a myocardial infarction. And we certainly do not believe that dialysis is
going to prevent myocardial infarction.
In fact, these patients having only
moderately good control of their blood
pressures (some have normal and some
have moderate elevation of blood pressures), obviously are going to be more
prone to the vascular complications of
hypertension than the normal population. But these deaths are the natural
ones, and the other deaths can virtually
be eliminated with proper training and
proper preparation.
The rehabilitation rate should also
increase as treatment is started earlier,
so you will not be dealing with moribund patients. A lot of the failure to
rehabilitate has been due, for instance,
to starting with a moribund patient
who gets severe neuropathy. This has
been the case in our one failure to rehabilitate, and an early start would
avoid this. As far as prognosis is concerned , the longest one is our patient
who has been five-and-one-half years
on dialysis. He is in better health now
than he has been at any time.
Limitations of Dialysis in Children

If you take the ideal group, dialysis
seems to be contraindicated currently
in the adolescent and the child, because
we have failed to maintain normal
growth and to effect sexual maturity in
the one patient we treated in this way
in Seattle. This does not mean that, with
improved membranes and improved
techniques, we will not be able to maintain normal growth. And this will be
a very sensitive assay of the adequacy
of dialysis. Even when confining ourselves to the age group of 15 to 45, we
have about 25 new patients per one
million population per year. In the
United States, there are about 5,000
new patients per year. If the life expectancy is 10 years, this means there
will be a patient population of 50,000.

This is indeed a staggering number of
patients. When we think of our present
technology, no wonder adequate treatment seems impossible. On the other
hand, I think we are just scratching the
surface of what is possible technically,
and I would like to underscore that by
briefly covering some of the advances
made since the program began.
Problems and Complications

The first problem we faced was loss
of the cannulas. Mr. Quinton correctly
diagnosed the reason as due to stiffness
in the teflon. The system would not
give with the normal rotation of the
limb, and we lost the cannulas in a
matter of months due to mechanical
failure. Infection has occurred, of
course, but it is largely due to abuse
of the cannulas by the patient, and
inability to cooperate in his daily care.
Mr. Quinton worked one year to extrude silicone rubber tubing that would
not clot, after Dow-Corning said that
it could not be done. Now all patients
on chronic dialysis have this shock absorber in the system which greatly
prolongs the life of the cannulas. The
first patient to get this kind of cannula was in the program in Seattle, and ,
three years later, he has the original
set. The usual life of these cannulas
extends from a few months to one-andone-half years, depending, mainly, on
how carefully the patient takes care of
his cannulated extremity. Certainly,
undue activity is the most important
factor in determining cannula failure.
We think the flexibility primarily accounts for the increased longevity of
the cannulas, compared with the old
teflon.
In Seattle, as in most centers, dialysis worked like this: it was an operating room procedure that took a
lot of work, a lot of people, and was
terribly expensive. Chronic dialysis
twice a week, using this approach, cost
from $20,000 to $30,000 per patient
per year. But in two years, starting with
the basic continuous system I mentioned, we have evolved the Seattle
continuous-flow, low-temperature system. We have turned it into a nursing
procedure. This makes possible, then,
the Seattle community center-type operation (under the direction of John
Murray, first, and now Jerry Pendras),
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where one nurse dialyses four patients
at once. The cost projections and the
pattern of operation of chronic dialysis all depend on the basic lessons
learned in this center, which was very
generously and very wisely funded by
the John A. Hartford Foundation in
1962. This center was built in the
basement of the nurses' home in Swedish Hospital. It shows what could be
done in the community, and that it
could be done outside the hospital or in
a low cost area. The cost of this type of
operation currently is $100 per dialysis,
or $10,000 per year for two treatments per week, including professional
fees. This is really the actual, total
cost. Rule off something such as construction and purchase of fixed equipment, and the cost is somewhat less.
We have made considerable progress
in understanding the diseases of dialysis. Clearly, all of these diseases, with
the exception of peripheral neuropathy, are due to inadequate dialysis.
The experience of the older days,
where you could not dialyze as much
as necessary, or the patients lost
weight, vomited, became malnourished,
and died, was simply because of inadequate dialysis. Gout, or gouty-like
arthritis which is an acute arthritis that
is responsive to colchicine and can be
reproduced by putting urate in the
bath, responds to adequate dialysis.
Metastatic calcifications dissolve if you
keep the phosphorous low enough with
dialysis, and peripheral neuropathy can
be stabilized by dialysis. But probably
the most important factor in peripheral
neuropathy in these patients is the
critical illness that may precede the
institution of therapy. Invariably, if
the patient becomes critically ill at the
time you start therapy, in a week or a
month he may develop a severe peripheral neuropathy. The degree of severity of this neuropathy varies tremendously from patient to patient, but
the clinical picture is constant. There
is now an excellent description of this
situation in the literature from the
Massachusetts General Hospital. The
prevention of neuropathy at this stage
of our understanding depends largely
on starting dialysis or doing the transplant before you are dealing with a
moribund patient. We have not yet
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defined diseases due to much dialysis,
but because our membrane is nonspecific, I am sure that some will be
defined. Secondary hyperparathyroidism is not a problem, but anemia is a
continuing problem. The average requirement, if you rinse your dialyzer
properly, is about two units of blood
per month. This is an area of obviously
great interest. If an erythropoetin could
be made available, we might eliminate
this. Stanley Sheldon in London believes that more intense dialysis and a
higher protein diet will minimize the
anemia.
The greatest problem for the patient
is controlled hypertension. The real
cross these patients must bear is learning to eat a low-salt diet. There is no
question that if he can learn a low-salt
diet, his blood pressure will be controlled. It takes from three to six
months for a patient to really learn to
eat a low-salt diet. They cannot cheat.
If they eat salt, they gain weight, and
it shows up on the scale when they
come into the center. Once they learn
it, their pressures are controlled either
at, or near, the normal level.
The Future of Hemodialysis

With this background, then, I am
going to talk briefly about my concept
of the future of management of
chronic uremia. One point I want to
make here is about good conservative care. This is an area which is
greatly misunderstood, both by nephrologists and by doctors in general.
The most important factor we have
found in the management of the
chronic is the control of hypertension
by means of sodium restriction. All
the emphasis in the literature on the
management of the chronic has been
on the salt-losing crisis and the magic
effects that salt has on a patient in
uremia. This is not the place to put
the emphasis. There is no question
that, if a patient is salt-depleted, and
his neck veins are flat and his blood
pressure is down, that his GFR will
drop almost to zero. Salt, then, can
have a miraculous, life-saving effect on
this patient. But for every one of these,
there are 500 patients who are being
abused by too much sodium. It is our
contention that it is the high blood

pressure induced by sodium overload,
rather than the disease itself, that is
most often responsible for progression
of the renal lesion to the fatal end. And
we have diagrammed this idea by
showing the maximum and a minimum
sodium excretion for a patient having
progressive loss of his kidney function
over a 30-year period. At some point,
he gets both a floor and a ceiling on
this ability to handle sodium. The inability to conserve sodium has gotten
all the emphasis because a few patients,
particularly those with pyelonephritis
and polycystic disease, waste sodium.
But as of now in our renal clinic, we
have about 30 chronics with serum
creatinines above 2, and there is only
one that is a significant salt waster. The
more important problem is that they
have an upper limit on their ability to
excrete sodium and when they start
taking in more than they can handle,
their blood pressure rises, they get
malignant hypertension, and die. We
give every patient a blue book to record his blood pressure, weight, and
urine volume, although the urine volume is not really important. Then we
teach them the relationship between
the amount of salt they eat, the change
in their weights, and the change in
their blood pressures. We saw a patient in 1960 who had "bad hypertension". The sole maneuver there was
to put him on sodium restriction. True,
his creatinine bounded around a little.
When first started, the creatinine will
always go up, which is another thing
that has received undue emphasis. As
long as it does not go up into the
symptomatic range, you should not
care. Because, if you are not going to
control that blood pressure, experience
shows that the man will be dead in a
matter of months. Four years later,
this patient's creatinine is still stable
around 8 and his blood pressure is well
controlled on a low salt diet. Occasionally it is well to add small doses of
blocking agents, but our experience
shows that patients with uremia tolerate these drugs very poorly. If they go
into dialysis, they are going to have to
go on a low salt diet anyway. We prefer to use the diet as our major therapeutic tool. All of our patients, we
feel, would have been dead within
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months had their blood pressures not
been controlled. So the message is,
control blood pressure by any means
that you can , and you are likely to get
a lot more mi leage out of your patient's
kidneys and avoid the day when definitive therapy is going to be needed. I am
not minimizing the importance of giving salt if the patient is sodium depleted, but this is a very special, rare
problem. What I am talking about is
the garden-variety, day-to-day management of the patient with renal insufficiency.
The Place of Peritoneal Dialysi>
Dr. Fred Bohn h as been working in
peritoneal dialysis for a number of
years, and his monograph is well
known. Eighteen months ago, peritoneal dialysis in the management of the
chronic was discredited, and rightly
so, because peritonitis was the rule.
Dr. Bohn devised an automatic cycling machine; which is a completely
closed dialysate system. He figured out
an experiment to sterilize these big
bottles of fluid so that no one has to
cycle the machine, thereby eliminating the need of the nurse or family.
Now, after having lost one patient with
peritonitis, he has a second patient going, and believes it is because of this
closed system which maintains sterility.
After three months of treating this
patient for recurrent peritonitis, he
resolved that the indwelling peritoneal
access prosthesis was the villain, and
to make a successful chronic peritoneal dialysis, he had to insert a peritoneal cannula every week, through a
tiny incision that heals from one week
to the next. Since he removed the
prosthesis, he has not had a bit of
trouble with peritonitis. It is on the
basis of comparing the patient who
loses significant amounts of protein
through the peritoneal membrane with
our patient on hemodialysis, that we
think that a synthetic membrane with
a larger pore size is needed.
Hemodialysis in Relation to Transplantation
We
future
hope
There

are very concerned about the
of dialysis in relation to the real
in this field, transplantation.
is no question that if you have

a human kidney inside you, working,
this is far superior to an artificial one.
You are not tied to a machine, you
don't have to worry about getting to
the center, you don't have to take care
of cannulas, and you don't have to eat
a low salt diet. But as we see them,
here are the facts on the current status
of transplantation: Of the identical
twins whose operations were performed five years ago, 70 % are now
dead of recurrent kidney disease. The
recurrence rate is 50 % in the Boston
group. We had a patient with glomerular nephritis who was sent to the Mayo
Clinic and transplanted from her
mother. Six days after the transplant,
the mother's kidney was destroyed by
the same disease that originally had
destroyed the patient's kidneys. This
is a very important case, of course. A
question raised is, had this patient
been carried for two or three years
on chronic dialysis, would this immune activity have abated and would,
then, the transplanted kidney have survived? If we get another such patient,
we will try a double transplant, probably first from a cadaver, doing it right
away, and then waiting two or three
years and trying it a second time. Dr.
Don Thomas, who is in charge of our
transpl ant program, recently reviewed
the latest summary from Dr. Joe Murray's group in Boston. He concluded
that the chances of surviving for two
years on a transplanted kidney are
somewhere between 5 and 20 % . The
chances of surviving for four years
probably are less than 1 % .
I can say with some conviction that
the chance of surviving four years on
chronic dialysis in the current well-run
program approaches 100%. The big if
in the dialysis program is that you
must have a cooperative patient. The
one thing stressed by all now doing
chronic dialysis is, if the p,atient cannot cooperate, take care bf his cannulas, or stay on the low salt diet,
then the chronic dialysis is not a very
good form of treatment. The amazing
thing we have found is that a group
of patients who are cooperating seem
to pull along the ones who are not,
especially during the early days when
they are learning about the program.
Most patients will cooperate, because

when they begin to feel well and see
what salt overload does to them, they
learn from bitter experience that it is
better to cooperate than to be sick.
I want to make another point that
I believe is important because of the
neuropathy problem. Despite economics and the intense need right now,
the sooner we make a logical transition
from good pre-dialysis care into dialysis, and into transplant after dialysis
without having a crisis, the sooner our
patients are going to be happier. Our
new clinic that will be opened at Swedish Hospital has the capacity for 30
new patients. Our patients who now
are being treated in town by the various kidney doctors have ·already visited the center. They know what they
are going to get into when the day
comes. They have heard about transplants, they are prepared emotionally,
and they are getting prepared financially to take on the definitive treatment, long before it will be necessary.
This is an ideal that we are far from
achieving. When we do achieve it, our
patients and doctors will be much
happier.
Home Dialysis
So the hope for the future rests on
lowering the cost of the present form
of treatment (the central pumping system is one example of how we are doing this with the important cooperation
of our engineering colleagues), some
form of home dialysis, and, of course,
the big hope is that we can make real
progress in the immunology of transplantation. Now we have a very exciting development, one that I think
offers real hope, particularly in the
financial area. That is home dialysis.
Our first patient on the home program
was a young high school girl who is
dialysed by our family in her basement.
The dialyser is a miniaturized version
of our central pumping system that is
fully automated. A standard Kiil dialyser is used. We switched from zepharin
or formaldehyde to acetic acid, a more
effective germicide that is often forgotten. When using acetic acid to
sterilize the artificial kidney, some is
left in, which the patient readily metabolizes. Then, when ready to dialyze,
you simply hook the kidney to the bath
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source, acetic acid becomes sodium
acetate, and you convert a germicide
into a metabolizable substance. Then,
as I mentioned, the dialysis fluid is
supplied by a miniaturized version of
our central pumping system or by a
home tank.
We started the patients in an isolated
area of the hospital, where the family
can be taught a little about what goes
on inside an artificial kidney. The family first observes the technique and
gradually begins to take over. It takes
a surprisingly short time to teach a
family to operate a system at home.
We totally underrated the motivation
of the patient to learn. The family
realizes it is their relative's life at stake,
and that if they do not learn to run the
equipment, they might well lose their
relative. They learn much faster than
our technicians and nurses who train
for our center program.
We are literally just scratching the
surface on what is going to be possible
in the home program. The cost, which
we hope is generous, looks like it is
going to be under $5 ,000 per year. The
breakdown is very encouraging, because such things as equipment, maintenance, and depreciation are the kind
of things communities can fund. This
leaves $3,000 or so per year for the
patient to pay. The startup costs are
around $8,500 for the first year. This
is a very rough figure; we do not have
enough experience with home dialysis
to know, but at least it is less than
half of what our current center type
of operation costs. (As of November
1965, there are seven patients on home
dialysis in Seattle, and there have been
no failures.)
The advantages of home dialysis,
in addition to the cost factor, is more
intensive dialysis. It can be done in the
evening, for example. Instead of spending the evening in the center, they
spend the evening at home. When an
unattended nighttime dialysis is possible, we have 56 hours a week during
the night to dialyze. This would then
free all of the patient's waking hours
for normal activities. A very important
point psychologically, is that the patient
himself becomes responsible for the
care instead of the institution. There is
a real feeling of independence.
6

Frequent short dialyses are more
effective. On twice-weekly dialysis, for
a total of 20 hours per week, the patient's creatinine got up to 12. On
three times per week, for a total of 18
hours or less time per week, his
creatinine got up to 10. So this kind of
study projects that the frequent short
dialyses are going to keep these patients much healthier than the infrequent, prolonged dialyses can.
One problem is that not everybody
is going to be able to go home. We
estimate, in our present population
of about 20 patients in Seattle, that
only half are going to go home. There
are going to be other solutions, but
the home program is the ultimate one.
The center type is perfectly satisfactory
if you can afford it, and something in
between may be the answer for other
patients. Maybe you can get them together in an apartment home- "You
dialyze me tonight and I'll dialyze you
tomorrow night"-This sounds crazy
but it will be necessary if people are
going to survive within the economic
limits we can provide.

